STOP PRESS: Harvard picks up Merck’s HRT account

Merck has handed the PR for its HRT patch Femseven to Harvard PR, firing Interscience, the specialist agency that launched the product to the medical press last year. Harvard picked up the account, thought to be worth pounds 50,000, in a competitive five-way pitch earlier this month.

Merck has handed the PR for its HRT patch Femseven to Harvard PR,

firing Interscience, the specialist agency that launched the product to

the medical press last year. Harvard picked up the account, thought to

be worth pounds 50,000, in a competitive five-way pitch earlier this

month.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.